CLLS Competitors & Alternatives
Compare Cellectis SA with similar stocks in the same industry
Biotechnology
CLLS
Main Stock$3.95
Tradestie Score
56
Market Cap
$330.07M
Revenue Growth
-0.2%
Analyst Upside
+83.5%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$25.18
|
$422.50M | - | 60 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$86.96
|
$410.79M | - | 56 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$13.30
|
$386.68M | - | 63 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$8.54
|
$371.64M | - | 64 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$30.91
|
$357.51M | - | 51 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$13.43
|
$354.45M | - | 51 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$31.43
|
$353.70M | - | 61 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.93
|
$350.98M | - | 50 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.82
|
$341.56M | - | 49 | Compare |
More CLLS Analysis
Data updated: May 03, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry